Angiogenesis inhibitors and activators from shark cartilage
US6379709B1 · kind B1 · utility
2Cited by
7References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 10, 1999 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | Dec 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A process for obtaining an angiogenesis inhibitor and an angiogenesis activator from shark cartilage comprising, as the key step, the aqueous extraction of dried shark cartilage. The angiogenesis inhibitor obtained is more potent than shark cartilage not subjected to the extraction step. The angiogenesis inhibitor is particularly useful for the prevention or treatment of cancer. The angiogenesis activator is particularly useful for stimulating wound healing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.